December 15, 2025

McKesson Corporation (MCK) Stock Analysis: Unlocking a 15% Upside Potential in the Healthcare Sector

McKesson Corporation (NYSE: MCK) stands as a formidable player in the healthcare sector, with a particular focus on medical distribution. With a market cap surpassing $101 billion, this Irving, Texas-based..

Genmab A/S (GMAB) Stock Analysis: A Biotechnology Powerhouse with 20.77% Upside Potential

Genmab A/S (NASDAQ: GMAB), a frontrunner in the biotechnology sector, is capturing the attention of investors with its robust pipeline of antibody-based cancer treatments and a promising potential upside of..

BeOne Medicines Ltd. (ONC): Consensus Signals 25.84% Upside Amid Robust Oncology Pipeline

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is making waves in the healthcare industry with its strong focus on oncology treatments. Headquartered in Basel, Switzerland, this..

Charles River Laboratories (CRL) Stock Analysis: Navigating Challenges with Strategic Collaborations

Charles River Laboratories International, Inc. (NYSE: CRL), a prominent player in the healthcare sector specializing in diagnostics and research, presents a mixed yet intriguing landscape for investors. With a market..

Universal Health Services, Inc. (UHS) Stock Analysis: Unpacking the 13.29% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) stands at a fascinating crossroads for investors interested in the healthcare sector. With a market capitalization of $14.17 billion, UHS is a formidable player..

IQVIA Holdings, Inc. (IQV): Investor Outlook Reveals 12.48% Potential Upside in Healthcare Powerhouse

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the diagnostics and research industry within the broader healthcare sector, is capturing investor attention with strong market fundamentals and growth potential. With..

Novartis AG (NVS) Stock Analysis: A Healthcare Giant with a 32.62% ROE and Promising Upside

Novartis AG (NYSE: NVS), a colossal player in the healthcare sector, continues to capture investor attention with its robust performance metrics and strategic focus on innovation. As a Swiss-based pharmaceutical..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 29.76% Potential Upside in Biotechnology

ADMA Biologics Inc. (NASDAQ: ADMA), a key player in the biotechnology sector, is capturing the attention of investors with its innovative approach to treating immune deficiencies and infectious diseases. With..

Grifols, S.A. (GRFS) Investor Outlook: Unpacking Potential Upside of Over 21%

Grifols, S.A. (NASDAQ: GRFS), a stalwart in the healthcare sector, particularly within the drug manufacturing industry, is capturing investor attention with a significant potential upside of 21.44%, according to recent..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating a Potential 3.46% Downside in a Volatile Healthcare Sector

Medpace Holdings, Inc. (NASDAQ: MEDP) has carved a niche in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Cincinnati, Ohio, Medpace offers an expansive range of..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare Growth with a Solid Dividend Yield

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector, is known for its innovative medical devices that cater to critical care and surgical applications. With a market capitalization of..

Quest Diagnostics (DGX) Stock Analysis: Navigating a Promising 8% Upside in Healthcare Diagnostics

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the Healthcare sector specializing in Diagnostics & Research, presents an intriguing opportunity for investors looking to capitalize on the evolving landscape..

Qiagen N.V. (QGEN) Investor Outlook: Assessing the 11.52% Potential Upside

For investors eager to explore opportunities within the healthcare sector, Qiagen N.V. (NASDAQ: QGEN) presents a compelling case. As a leading player in the diagnostics and research industry, Qiagen, headquartered..

Becton, Dickinson and Company (BDX) Stock Analysis: Insights into a Healthcare Giant’s 1.05% Potential Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, commands a significant presence in the medical instruments and supplies industry. With a market capitalization of $57.58 billion,..

Ionis Pharmaceuticals (IONS) Stock Analysis: A Strategic Biotech with 6.17% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, is capturing investor attention with its strategic focus on RNA-targeted medicines. With a market capitalization of $13.09 billion,..

Legend Biotech Corporation (LEGN) Stock Analysis: A Potential 223.95% Upside with Promising CAR-T Therapy Innovations

Legend Biotech Corporation (NASDAQ: LEGN) presents an intriguing opportunity for investors within the healthcare sector, particularly those with an interest in biopharmaceutical innovations. With a market capitalization of $4.12 billion,..

Bruker Corporation (BRKR) Investor Outlook: Analyzing a 10.16% Potential Upside

Bruker Corporation (NASDAQ: BRKR) is a prominent player in the healthcare sector, specifically within the medical devices industry. With its headquarters in Billerica, Massachusetts, Bruker has carved out a significant..

Summit Therapeutics Inc. (SMMT) Investor Outlook: A Biotech Play with 84.83% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT), with a market cap of $13.08 billion, presents a compelling opportunity for investors seeking exposure in the healthcare sector, specifically within the dynamic field of..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a 3.37% Potential Upside in the Healthcare Sector

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, has long been a name synonymous with innovation and quality in the pharmaceutical industry. Headquartered in Hyderabad,..

Globus Medical, Inc. (GMED) Stock Analysis: Strong Revenue Growth and Promising Upside Potential

Globus Medical, Inc. (NYSE: GMED), a leader in the medical devices sector, is capturing the attention of investors with its robust revenue growth and promising stock potential. With a market..

Search

Funds

December 15, 2025

Search

Funds

December 15, 2025

FTSE 100

Funds